You have read all your free articles, to continue reading subscribe to read the rest of this content.
NorthX Biologics has acquired the Stockholm-based Clinical Trial Manufacturing unit from Valneva Sweden. The acquisition includes the transfer of a multi-purpose facility, situated in the Stockholm life science cluster, close to Karolinska University Hospital. In addition, 30 staff members whoAlready a subscriber Login You have read all your free articles,…
On behalf of the Swedish government, the Swedish innovation agency Vinnova has decided on funding of an innovation cluster for commercialization, competence development and production capacity for advanced therapies. The new cluster will serve as a national infrastructure and competence node for Already a subscriber Login You have read all…
Budesonide/glycopyrronium/formoterol fumarate has been approved in China for the maintenance treatment of chronic obstructive pulmonary disease (COPD). This is the first approval by the National Medical Products Administration for a triple-combination therapy in a pressurised metered-dose inhalerAlready a subscriber Login You have read all your free articles, to continue reading…
AstraZeneca and MSD’s Lynparza has been approved in the US for the adjuvant treatment of patients with germline BRCA-mutated HER2-negative high-risk early breast cancer who have already been treated with chemotherapy either before or after surgery. The approval by the US Food and Drug AdministrAlready a subscriber Login You have…
